Pyxis Oncology, Inc. — Investor Relations & Filings
Pyxis Oncology, Inc. is a clinical-stage company focused on developing next-generation therapeutics for difficult-to-treat cancers. The company's differentiated portfolio of clinical assets is centered on two primary modalities: antibody-drug conjugates (ADCs) and immuno-oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for enhanced safety and efficacy. The immuno-oncology programs utilize monoclonal antibodies (mAbs) to mobilize the body's immune system to attack cancer cells by blocking tumor defense mechanisms and overcoming immune suppression. Pyxis Oncology is advancing its product candidates as both monotherapies and in combination with other therapies to improve outcomes for patients with solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4 SUBMISSION | 2023-09-08 | English | |
| FORM 4 SUBMISSION | 2023-09-08 | English | |
| FORM 4 SUBMISSION | 2023-09-08 | English | |
| Regulatory Filings 2023 | 2023-09-06 | English | |
| Regulatory Filings 2023 | 2023-09-05 | English | |
| Regulatory Filings 2023 | 2023-08-29 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13190875 | FORM 4 SUBMISSION | 2023-09-08 | English | ||
| 13190876 | FORM 4 SUBMISSION | 2023-09-08 | English | ||
| 13190877 | FORM 4 SUBMISSION | 2023-09-08 | English | ||
| 13190878 | Regulatory Filings 2023 | 2023-09-06 | English | ||
| 13190879 | Regulatory Filings 2023 | 2023-09-05 | English | ||
| 13190880 | Regulatory Filings 2023 | 2023-08-29 | English | ||
| 13190881 | FORM 4 SUBMISSION | 2023-08-25 | English | ||
| 13190882 | FORM 3 SUBMISSION | 2023-08-25 | English | ||
| 13190883 | Regulatory Filings 2023 | 2023-08-25 | English | ||
| 13190884 | FORM S-8 POS | 2023-08-23 | English | ||
| 13190885 | FORM POS AM | 2023-08-23 | English | ||
| 13190886 | FORM S-8 | 2023-08-23 | English | ||
| 13190888 | 8-K | 2023-08-23 | English | ||
| 13190887 | Regulatory Filings 2023 | 2023-08-16 | English | ||
| 13190893 | Regulatory Filings 2023 | 2023-08-11 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Pyxis Oncology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33976/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33976 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33976 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33976 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33976}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pyxis Oncology, Inc. (id: 33976)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.